• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

    78.98 +0.45 (+0.57%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,881,209
    Open 79.58
    Bid (Size) 76.00 (100)
    Ask (Size) 85.00 (300)
    Prev. Close 78.53
    Today's Range 78.10 - 80.00
    52wk Range 43.17 - 87.50
    Shares Outstanding 81,474,366
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Scores Perfect 10/10 For Technical Breakout Setup ↗
    Via Chartmill
    News headline image
    Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% ↗
    This clinical-stage biotech develops targeted oral therapies for RAS/MAPK-driven cancers, with all assets currently in development. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +2.9%
    +2.9%
    1 Month
    +12.3%
    +12.3%
    3 Month
    +17.7%
    +17.7%
    6 Month
    +5.9%
    +5.9%
    1 Year
    +56.6%
    +56.6%

    More News

    Read More
    News headline image
    Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More ↗
    Via The Motley Fool
    News headline image
    PTC Therapeutics Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    PTC Therapeutics Inc (NASDAQ:PTCT) Delivers Q1 Earnings Beat and Raises 2026 Guidance ↗
    Via Chartmill
    Topics Earnings
    PTC Therapeutics Inc (NASDAQ:PTCT) Stock Slides After Q4 Earnings Miss ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill
    News headline image
    PTCT Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Moderate Valuation ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Combines High-Growth Momentum with Bullish Technical Setup ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Emerges as a High-Growth Momentum Breakout Candidate ↗
    Via Chartmill
    News headline image
    This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    PTC Therapeutics Inc (NASDAQ:PTCT) Combines Strong Growth with a Bullish Technical Setup ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT): A Prime Candidate for Affordable Growth Investing ↗
    Via Chartmill
    News headline image
    Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Shows High-Growth Momentum and Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill
    News headline image
    PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Reasonable Valuation ↗
    Via Chartmill
    News headline image
    Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is PTC Therapeutics, Inc. - Common Stock publicly traded?
    Yes, PTC Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does PTC Therapeutics, Inc. - Common Stock trade on?
    PTC Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for PTC Therapeutics, Inc. - Common Stock?
    The ticker symbol for PTC Therapeutics, Inc. - Common Stock is PTCT on the Nasdaq Stock Market
    What is the current price of PTC Therapeutics, Inc. - Common Stock?
    The current price of PTC Therapeutics, Inc. - Common Stock is 78.98
    When was PTC Therapeutics, Inc. - Common Stock last traded?
    The last trade of PTC Therapeutics, Inc. - Common Stock was at 06/18/26 04:00 PM ET
    What is the market capitalization of PTC Therapeutics, Inc. - Common Stock?
    The market capitalization of PTC Therapeutics, Inc. - Common Stock is 6.43B
    How many shares of PTC Therapeutics, Inc. - Common Stock are outstanding?
    PTC Therapeutics, Inc. - Common Stock has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.